Vaxcyte Inc.
Cash Flow Statement
| Line Item | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-48.5M | $-39.0M | $-28.6M | $-26.6M | $-23.7M | $-21.2M | $-20.7M | $-21.0M |
| Depreciation & Amortization | $600.0K | $582.0K | $453.0K | $500.0K | $500.0K | $347.0K | $321.0K | $300.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $5.9M | $4.1M | $3.2M | $2.9M | $2.8M | $1.9M | $1.9M | $1.8M |
| Net Cash from Operating Activities | $-39.1M | $-27.7M | $-51.1M | $-28.4M | $-28.7M | $-13.2M | $-10.8M | $-13.1M |
| Investing Activities | ||||||||
| Capital Expenditures | $938.0K | $2.9M | $1.4M | $1.7M | $2.2M | $1.2M | $722.0K | $29.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $26.2M | $49.7M | $82.0K | $-18.5M | $-20.5M | $-173.4M | $-722.0K | $21.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $49.9M | $111.0M | $8.8M | $7.6M | $956.0K | $487.0K | $555.0K | $36.0K |
| Net Change in Cash | $36.4M | $132.8M | $-43.1M | $-39.0M | $-47.9M | $-186.4M | $-10.8M | $-13.0M |
| Free Cash Flow | $-40.1M | $-30.6M | $-52.5M | $-30.1M | $-30.9M | $-14.5M | $-11.5M | $-13.1M |